Hood River Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-20,163
Closed -$6.76M 103
2019
Q3
$6.76M Buy
+20,163
New +$6.46M 0.35% 84

Other funds holding CDLX

Hood River Capital Management's CDLX Position: Q4 2019 in Review

Hood River Capital Management sold out of Cardlytics (CDLX) in Q4 2019, closing a stake of 20,163 shares — an estimated $6.76M sold.

Hood River Capital Management first reported a position in CDLX in Q3 2019 and held it in 1 quarter. The position peaked at $6.76M in Q3 2019. 156 funds tracked by Wall St. Rank hold CDLX as of Q4 2019.

  • Hood River Capital Management reported no remaining Cardlytics position as of Q4 2019 after selling out during the quarter.
  • Hood River Capital Management sold 20,163 Cardlytics shares in Q4 2019, an estimated $6.76M.
  • Hood River Capital Management first reported a position in Cardlytics in Q3 2019 and held it in 1 quarter.
  • Hood River Capital Management's Cardlytics position peaked at $6.76M in Q3 2019.
  • 156 funds tracked by Wall St. Rank held Cardlytics as of Q4 2019.

Based on Hood River Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.